Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G/A for ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS).
- Disclosed ownership: 5.7%.
- Date of event: 31 Mar 2025.
CVI Investments, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- RSLS
- Shares outstanding
- 3,508,772 shares
- Disclosed Ownership
- 200,000 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 May 2025, 12:11:03 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 21 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 5.7% ownership in ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 21 Feb 2025.
- Current filing was accepted on 12 May 2025, 12:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 5.7% | 200,000 | 0 | 200,000 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 5.7% | 200,000 | 0 | 200,000 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary |